Next to Normal Rocks Broadway Box Office in Final Week | Playbill

Related Articles
News Next to Normal Rocks Broadway Box Office in Final Week Next to Normal, the Tony Award and Pulitzer Prize-winning musical by Tom Kitt and Brian Yorkey, broke the box-office record at the Booth Theatre during its final week of performances.

The acclaimed musical about an American family struggling to hold together ended its almost two-year Broadway run Jan. 16. The rock musical grossed $552,653 for its final week of performances, beating its previous record of $550,409. Next to Normal recouped its $4 million Broadway investment last spring.

The final cast included Tony Award nominee Marin Mazzie, Jason Danieley, Kyle Dean Massey, Meghann Fahy and original cast members Adam Chanler-Berat and Louis Hobson.

Next to Normal arrived on Broadway in March 27, 2009, and officially opened April 15, 2009, at the Booth Theatre. Michael Greif directed the musical, which ran for 21 previews and 733 performances.

Kitt (music) and Yorkey (book/lyrics) authored the musical about a mother battling depression and bi-polar disorder, which also delves into prescription drug abuse, suicide, grief and the breakdown of an American family.

Next to Normal earned Tony Awards for Best Score (Kitt/Yorkey), Best Orchestrations (Kitt/Michael Starobin), Best Actress (Alice Ripley) and received Tony nominations for Best Musical, Best Book of a Musical, Best Featured Actress (Jennifer Damiano), Best Actor (J. Robert Spencer), Best Direction (Michael Greif), Best Scenic Design, Best Lighting Design and Best Sound Design. It was also awarded the 2010 Pulitzer Prize for Drama. Broadway producers are David Stone, James L. Nederlander, Barbara Whitman, Patrick Catullo and Second Stage Theatre.

Next to Normal is currently on tour with original star Ripley recreating her performance as Diana.

Visit NexttoNormal.

 
RELATED:
Today’s Most Popular News:
 X

Blocking belongs
on the stage,
not on websites.

Our website is made possible by
displaying online advertisements to our visitors.

Please consider supporting us by
whitelisting playbill.com with your ad blocker.
Thank you!